Christina Chu is an Oncology physician affiliated with Cooper Medical School of Rowan University. OpenAlex indexes 179 publications with 8,744 citations (h-index 41); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2 Cooper Plz
Camden, NJ 081031461
Telephone
855-632-2667Provider last certified this registry record 17 Apr 2023.
Clinical trials
- Phase I, Open-Label Study of the Safety, Tolerability, and Immunogenicity PEK Fusion Protein Vaccine
Sponsor: HealthBanks Biotech Co., Ltd.
- Phase I of Human Papillomavirus (HPV) DNA Plasmid (VGX-3100) + Electroporation for CIN 2 or 3
Sponsor: Inovio Pharmaceuticals
- Dendritic Cell Vaccine for High Risk Ovarian Cancer Patients
Sponsor: University of Pennsylvania
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GlaxoSmithKline, LLC.Program year20251 payment
- Merck Sharp & Dohme LLCProgram year20251 payment
- GlaxoSmithKline, LLC.Program year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2023 - NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021
Journal of the National Comprehensive Cancer Network
2021 - NCCN Guidelines Insights: Cervical Cancer, Version 1.2020
Journal of the National Comprehensive Cancer Network
2020 - Prognosticating for Adult Patients With Advanced Incurable Cancer: a Needed Oncologist Skill
Current Treatment Options in Oncology
2020 - Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Annette Reboli, MD
Cooper Medical School of Rowan University
Allen Seftel, MD
Cooper Medical School of Rowan University
Timothy Averch, MD
Cooper Medical School of Rowan University
Jerome Check, MD, PhD
Cooper Medical School of Rowan University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”